As of April 29, 2025, Vaxxinity (VAXX) has a market cap of $0.15 billion USD. According to our data, Vaxxinity is ranked No.7284 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $0.15 B |
26,877.01%
|
Dec 31, 2024 | $0.56 M |
-99.41%
|
Dec 29, 2023 | $95.97 M |
-39.29%
|
Dec 30, 2022 | $0.16 B |
-75.04%
|
Dec 31, 2021 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$10.57 B |
-0.043 B
|
![]() USA
|
![]() BioNTech
BNTX
|
$25.00 B |
0.001 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$1.14 B |
64.676 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$373.78 B |
0.011 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$216.81 B |
0.006 M
|
![]() UK
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Merck
MRK
|
$209.34 B |
0.002 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.79 B |
7.256 M
|
![]() Germany
|
![]() Inovio Pharmaceuticals
INO
|
$71.17 M |
1.853 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.39 B |
10.199 M
|
![]() USA
|
![]() Arcturus Therapeutics
ARCT
|
$0.35 B |
0.000 M
|
![]() USA
|
![]() Valneva SE
VALN
|
$0.56 B |
7.532 M
|
![]() France
|
Market Cap | = | VAXX Stock Price | * | VAXX Shares Outstanding |
= | $0.02 | * | 0.11 B | |
= | $0.15 B |